Extended-release minocycline (Solodyn) for acne

Medical Letter on Drugs and Therapeutics

Volumn 48, Issue 1248, 2006, Pages 95-96

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BENZOYL PEROXIDE; DOXYCYCLINE; ERYTHROMYCIN; ISOTRETINOIN; MINOCYCLINE; ORAL CONTRACEPTIVE AGENT; PLACEBO; RETINOID; SOLODYN; TETRACYCLINE;

ACNE; ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; BONE DEVELOPMENT; CLINICAL TRIAL; DISEASE SEVERITY; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG COST; DRUG DOSE COMPARISON; DRUG FORMULATION; DRUG RELEASE; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; HUMAN; RECOMMENDED DRUG DOSE; SEBACEOUS GLAND; SHORT SURVEY; SIDE EFFECT; TOOTH DISCOLORATION; VAGINA CANDIDIASIS; VERTIGO; ACNE VULGARIS; ARTICLE; DELAYED RELEASE FORMULATION;

ACNE VULGARIS; DELAYED-ACTION PREPARATIONS; HUMANS; MINOCYCLINE;

EID: 39049186007     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (6)

1. Drugs for acne, rosacea and psoriasis. Treat Guidel Med Lett 2005; 3:49.
2. SE Garner et al. Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev 2003; (1):CD002086.
3. M Ozolins et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet 2004; 364:2188.
4. JJ Leyden. New extended-release minocycline: first systemic antibiotic approved for the treatment of acne - introduction. Cutis 2006; 78 suppl 4:4.
5. AB Fleischer Jr et al. Safety and efficacy of a new extended-release formulation of minocycline. Cutis 2006; 78 suppl 4:21.
6. DM Stewart et al. Dose-ranging efficacy of new once-daily extended-release minocycline for acne vulgaris. Cutis 2006; 78 suppl 4:11.